$121,042,404
to PUBLIC HEALTH, MASSACHUSETTS DEPARTMENT OF
MASSACHUSETTS STATE OPIOID RESPONSE (SOR) PROGRAM - THE PURPOSE OF THE ONGOING MA SOR PROGRAM IS TO ADDRESS THE OVERDOSE CRISIS IN MASSACHUSETTS BY INCREASING ACCESS TO FDA-APPROVED MEDICATIONS FOR THE TREATMENT OF OPIOID USE DISORDER (MOUD), AND SUPPORTING THE CONTINUUM OF PREVENTION, HARM REDUCTION, TREATMENT, AND RECOVERY SUPPORT SERVICES FOR OPIOID USE DISORDER (OUD), STIMULANT USE DISORDERS, AND OTHER CONCURRENT SUBSTANCE USE DISORDERS (SUD). POPULATIONS TO BE SERVED INCLUDE THESE HIGH RISK POPULATIONS: BLACK, INDIGENOUS, AND PEOPLE OF COLOR (BIPOC), LGBTQIA+, INDIVIDUALS WHO HAVE EXPERIENCED A PRIOR NONFATAL OVERDOSE, YOUTH AND FAMILIES IMPACTED BY THE OPIOID CRISIS, PERSONS WITH HISTORY OF INCARCERATION, PREGNANT AND PARENTING WOMEN, INDIVIDUALS EXPERIENCING HOMELESSNESS, INDIVIDUALS AT RISK OF CONTRACTING AND/OR CURRENTLY LIVING WITH INFECTIOUS DISEASE, PEOPLE WHO USE STIMULANTS ALONE AND/OR WITH OTHER DRUGS, AND PERSONS WITH CO-OCCURRING MENTAL HEALTH DISORDERS. GOALS INCLUDE GOAL 1: INCREASE ACCESS TO EVIDENCE-BASED TREATMENT FOR PEOPLE WITH OPIOID AND/OR STIMULANT USE DISORDERS. GOAL 2: SUPPORT THE FULL CONTINUUM OF PREVENTION, HARM REDUCTION, TREATMENT, AND RECOVERY SUPPORT SERVICES FOR TRANSITIONAL AGED YOUTH AND YOUNG ADULTS. GOAL 3: INCREASE ACCESS TO RECOVERY SUPPORT SERVICES FOR PEOPLE WITH OR AT RISK FOR DEVELOPING OPIOID AND/OR STIMULANT USE DISORDERS. GOAL 4: INCREASE ACCESS TO OVERDOSE PREVENTION EDUCATION, HARM REDUCTION AND DRUG USER HEALTH SERVICES. GOAL 5: STRENGTHEN THE WORKFORCE’S ABILITY TO PROVIDE EVIDENCE-BASED PREVENTION, INTERVENTION, TREATMENT AND RECOVERY SUPPORT SERVICES TO PEOPLE WITH OPIOID AND/OR STIMULANT USE DISORDERS. TOTAL NUMBER TO BE SERVED OVER THE PROJECT PERIOD: 62,035 INDIVIDUALS (9,185 OF WHICH WILL BE GPRA ELIGIBLE).
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Fund Massachusetts opioid response program expanding access to medication-assisted treatment and harm reduction services for people with opioid and stimulant use disorders.
Addresses the ongoing overdose crisis through evidence-based treatment and recovery support, targeting vulnerable populations including BIPOC, LGBTQIA+, and unhoused individuals.
Increases demand for FDA-approved medications for opioid use disorder (buprenorphine, methadone, naltrexone) and clinical workforce training capacity.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002816.
- 2026-04-06BUILDING AND ENHANCING EPIDEMIOLOGY, LABORATORY AND HEALTH INFORMATION SYSTEMS CAPACITY IN MASSACHUSETTS$1.1B
- 2026-04-20CDC-RFA-IP19-1901 IMMUNIZATION AND VACCINES FOR CHILDREN$194.3M
- 2026-04-20RYAN WHITE CARE ACT TITLE II$132.5M
- 2026-02-20THE PURPOSE OF THE MASSACHUSETTS STATE OPIOID RESPONSE (SOR) PROGRAM IS TO ENHANCE OUR CAPACITY TO ADDRESS THE ONGOING OPIOID CRISIS IN MASSACHUSETTS.$113.9M
- 2026-05-04WIC FOOD EXPENSE$84.5M
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_H79TI087779_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.